| 000 | 01295 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514025123.0 | ||
| 264 | 0 | _c20020327 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0013-9580 | ||
| 024 | 7 |
_a10.1046/j.1528-1157.2001.0420s5044.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoden, D M | |
| 245 | 0 | 0 |
_aPrinciples in pharmacogenetics. _h[electronic resource] |
| 260 |
_bEpilepsia _c2001 |
||
| 300 |
_a44-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xdrug effects |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2D6 Inhibitors |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 |
_aGenes, MDR _xgenetics |
| 650 | 0 | 4 |
_aGenomics _xtrends |
| 650 | 0 | 4 | _aHuman Genome Project |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIon Channels _xgenetics |
| 650 | 0 | 4 |
_aLong QT Syndrome _xchemically induced |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xchemistry |
| 650 | 0 | 4 |
_aPharmacogenetics _xtrends |
| 650 | 0 | 4 |
_aPharmacology _xtrends |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 773 | 0 |
_tEpilepsia _gvol. 42 Suppl 5 _gp. 44-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1528-1157.2001.0420s5044.x _zAvailable from publisher's website |
| 999 |
_c11794606 _d11794606 |
||